Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
China flag China · Delayed Price · Currency is CNY
51.38
+0.25 (0.49%)
At close: Apr 17, 2026

SHA:688193 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-7.818.2623.3364.62
Depreciation & Amortization
16.915.5714.4510.02
Other Amortization
2.6521.50.77
Loss (Gain) From Sale of Assets
-0.140.05-0.14-0.76
Asset Writedown & Restructuring Costs
0.830.341.190.38
Loss (Gain) From Sale of Investments
-10.49-6.16-9.32-1.21
Provision & Write-off of Bad Debts
16.830.592.921.01
Other Operating Activities
2.820.4310.76
Change in Accounts Receivable
9.4526.66-49-19.57
Change in Inventory
2.490.05-10.09-2.8
Change in Accounts Payable
-4.13-21.4222.32-9.63
Change in Other Net Operating Assets
2.28-4.162.427.95
Operating Cash Flow
24.3917.19-4.0954.44
Operating Cash Flow Growth
41.85%---41.21%
Capital Expenditures
-10.52-20.39-21.22-26.48
Sale of Property, Plant & Equipment
1.120.390.71.94
Investment in Securities
-323.75315-530-0.13
Other Investing Activities
11.176.928.831.21
Investing Cash Flow
-321.99301.92-541.68-23.45
Short-Term Debt Repaid
----3.84
Long-Term Debt Repaid
-3.27-3.97-1.26-1.98
Total Debt Repaid
-3.27-3.97-1.26-5.82
Net Debt Issued (Repaid)
-3.27-3.97-1.26-5.82
Issuance of Common Stock
--675.69-
Repurchase of Common Stock
-35.66---
Common Dividends Paid
-11.71-5--0.05
Other Financing Activities
---27.140.91
Financing Cash Flow
-50.64-8.97647.29-4.97
Foreign Exchange Rate Adjustments
0.560.48-0.15-0.36
Net Cash Flow
-347.69310.63101.3725.67
Free Cash Flow
13.86-3.2-25.3127.97
Free Cash Flow Growth
----63.71%
Free Cash Flow Margin
7.82%-1.94%-8.33%9.57%
Free Cash Flow Per Share
0.35-0.08-0.660.92
Cash Income Tax Paid
6.97.3418.8417.9
Levered Free Cash Flow
18.4-10.09-29.74-3.93
Unlevered Free Cash Flow
18.59-9.82-29.51-3.77
Change in Working Capital
2.8-3.91-39.03-21.14
Source: S&P Global Market Intelligence. Standard template. Financial Sources.